News
Through its Precision Care Companion, McKesson wants to help oncologists bring personalized medicine to their patients ...
1d
Barchart on MSNEarnings Preview: What To Expect From Cencora's ReportValued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in ...
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter ...
The segment’s performance is expected to have remained strong in the first quarter as well, driven by growth in ...
Cencora COR -0.56% Get Free Report has outperformed the market over the past 5 years by 12.25% on an annualized basis ...
This article summarizes the most significant insider buying and selling activities reported on Wednesday for US stocks.
Drug distributors like Cardinal Health, Cencora and McKesson will play a key role in the drug supply chain, improving patient ...
The biggest companies in the world call the S&P 500 (\^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and ...
3d
Zacks Investment Research on MSNHCA Healthcare to Report Q1 Earnings: Key Estimates to NoteHospital operator HCA Healthcare, Inc. HCA is set to report first-quarter 2025 results on April 25, 2025, before the opening ...
Manufacturing Digital explores the top supply chains in the healthcare industry that ensure manufacturers can produce and ...
Cencora Inc. closed 3.50% below its 52-week high of $296.65, which the company reached on April 4th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results